Real-world experience of using ciclosporin-A 0.1% in the management of ocular surface inflammatory diseases

PURPOSE: To report the real-world experience of using topical ciclosporin, Ikervis, in the management of ocular surface inflammatory diseases (OSIDs). METHODS: This was a retrospective study of patients treated with Ikervis for OSIDs at the Queen’s Medical Centre, Nottingham, between 2016 and 2019....

Descripción completa

Detalles Bibliográficos
Autores principales: Deshmukh, Rashmi, Ting, Darren Shu Jeng, Elsahn, Ahmad, Mohammed, Imran, Said, Dalia G, Dua, Harminder Singh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340021/
https://www.ncbi.nlm.nih.gov/pubmed/33687999
http://dx.doi.org/10.1136/bjophthalmol-2020-317907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340021/
https://www.ncbi.nlm.nih.gov/pubmed/33687999
http://dx.doi.org/10.1136/bjophthalmol-2020-317907

Ejemplares similares